Dgci Issues Show Cause Notice To Serum Institute Over Ongoing Clinical Trial Of Covishield Vaccine

DGCI Issues Show Cause Notice To Serum Institute Over Ongoing Clinical Trial Of Covishield Vaccine

Oxford vaccine India trial on hold after DGCI notice

Serum Institute halts India trials of COVID vaccine; Astrazeneca out from COVID vaccine race

DGCI Issues Show-cause Notice To Serum Institute For Not Halting Trial Of COVID-19 Vaccine

Serum Institute pauses India trials of AstraZeneca's COVID-19 vaccine after DCGI's notice

The Economic Times

Serum Institute Seeks DGCI Nod For Clinical Trials Of Covid Vaccine Covavax | India Today

Adar Poonawalla's Serum Institute Gets Notice On Pausing Vaccine Trial

NDTV

Oxford covid Vaccine DCGI Issues Show-Cause Notice | to Serum Institute

Oxford Covid Vaccine Trials To Be Conducted In India Soon, Serum Institute Seeks DGCI Nod

DGCI Issues Notice To Serum Institute For Not Halting Oxford COVID-19 Vaccine Trial

Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine

Covaxin & Covishield ready for a rollout;What are the concerns regarding the vaccine | The Big Story

AstraZeneca-Oxford vaccine trials halted in India after DGCI's notice

Govt issues show-cause notice to Serum institute; Pune Institute asked to explain the vaccine status

Serum Institute halts Covishield trials in India

Covid-19 News: Serum Institute To Pause Vaccine Trials In India After Drug Controller's Notice

NDTV

Will AstraZeneca’s Paused COVID-19 Vaccine Trial Impact The Ongoing Trials In India?

COVID-19 Vaccine: Serum Institute Gets Nod For Phase 2, 3 Clinical Trials Of Oxford Covid Vaccine

Headlines: Serum Institute of India Halts Oxford Coronavirus Vaccine Trials In India

HW News English

Covid-19 Vaccine Update: Serum Institute Halts Trials For Oxford Vaccine Candidate